Novartis India surges 7% as board mulls share buyback

So far in 2017, the stock under-performed the market by falling 24% as compared to 22% rise in the S&P BSE Sensex till Wednesday.

Novartis
Novartis is addressing the pricing question with a new type of agreement: For patients whose care is covered by the US govt programmes, the company will only get paid if patients show signs that the treatment is working within a month | Photo: istock
SI Reporter Mumbai
Last Updated : Sep 21 2017 | 9:54 AM IST
Novartis India surged 7% to Rs 697 on BSE in early morning trade after the pharmaceuticals company said that the board will meet on Monday, September 25, 2017 to consider a proposal for buyback of the company's equity shares.
 
As of June 2017, the promoters held 73.4% stake in Novartis India. The public shareholders holding the remaining 26.6% stake, of which 20.5% holding are with the individual shareholders.

Earlier, in September 2016, Novartis had bought back 3.82 million shares of the company at a price of Rs 760 per share.

Thus far in the calendar year 2017, the stock has underperformed the market by falling 24% as compared to 22% rise in the S&P BSE Sensex till Wednesday.

At 9:37 am, the stock was up 5% at Rs 679 against 0.09% rise in the benchmark index. The trading volumes on the counter jumped an over seven-fold. Around 79,000 shares changed hands on BSE against an average 11,000 shares were traded in past two weeks.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story